Want to see AIRS full AI Analyst Report?
AIRS Stock Chart & Stats
$2.72
$0.15(3.25%)
At close: 4:00 PM EDT
$2.72
$0.15(3.25%)
Day’s Range― - ―
52-Week Range$1.51 - $12.00
Previous CloseN/A
Volume200.44K
Average Volume (3M)947.78K
Market Cap
$188.17M
Enterprise Value$371.18
Total Cash (Recent Filing)$18.82M
Total Debt (Recent Filing)$70.47M
Price to Earnings (P/E)―
Beta2.54
Next Earnings
Nov 05, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend Yield4.45%
Share Statistics
EPS (TTM)-0.18
Shares Outstanding72,095,210
10 Day Avg. Volume852,352
30 Day Avg. Volume947,782
Financial Highlights & Ratios
PEG Ratio-0.29
Price to Book (P/B)1.36
Price to Sales (P/S)0.79
P/FCF Ratio172.97
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$6.00Price Target Upside120.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.04
Revenue Forecast (FY)$153.19M
Bulls Say, Bears Say
Bulls Say
Debt Reduction And LiquidityMaterial debt reduction and a larger equity base improve financial flexibility and reduce balance-sheet pressure. This gives AirSculpt more capacity to fund clinics, marketing, and service expansion while lowering the burden that leverage can place on future cash generation.
Resilient Gross Margins And Operating StabilizationStable gross profitability indicates the core procedure economics remain attractive despite revenue pressure. Recent case growth, improving same-center trends, and positive adjusted EBITDA suggest operations may be stabilizing, supporting a credible path toward better earnings as utilization improves.
Expanded Procedure PortfolioBroadening the service portfolio can increase the number of patients AirSculpt can serve and create more revenue opportunities within its owned-center network. New procedures also diversify reliance on traditional fat-removal services, although adoption will take time to scale.
Bears Say
Sustained Revenue Contraction And LossesThe prolonged top-line decline shows that AirSculpt has not yet restored prior demand levels, while continuing net losses indicate gross profit is insufficient to cover operating costs. This weakens internal funding capacity and makes durable earnings recovery dependent on renewed growth.
Recent Cash BurnNegative operating and free cash flow reduce the company’s ability to fund expansion and marketing from internally generated resources. If cash conversion remains weak over the next several quarters, AirSculpt may need to rely more heavily on financing or slow investment.
Elevated Customer Acquisition Costs And Softer DemandHigher acquisition costs can compress procedure-level economics and make growth less efficient, particularly when demand is already softening. The combination raises the amount AirSculpt must spend to maintain volume and increases execution risk for its marketing-led recovery plan.
Airsculpt Technologies News
AIRS FAQ
What was Airsculpt Technologies, Inc.’s price range in the past 12 months?
Airsculpt Technologies, Inc. lowest stock price was $1.51 and its highest was $12.00 in the past 12 months.
What is Airsculpt Technologies, Inc.’s market cap?
Airsculpt Technologies, Inc.’s market cap is $188.17M.
When is Airsculpt Technologies, Inc.’s upcoming earnings report date?
Airsculpt Technologies, Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 54 days.
How were Airsculpt Technologies, Inc.’s earnings last quarter?
Airsculpt Technologies, Inc. released its earnings results on Aug 10, 2026. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.015 by -$0.005.
Is Airsculpt Technologies, Inc. overvalued?
According to Wall Street analysts Airsculpt Technologies, Inc.’s price is currently Undervalued.
Does Airsculpt Technologies, Inc. pay dividends?
Airsculpt Technologies, Inc. pays a Notavailable dividend of $0.41 which represents an annual dividend yield of 4.45%. See more information on Airsculpt Technologies, Inc. dividends here
What is Airsculpt Technologies, Inc.’s EPS estimate?
Airsculpt Technologies, Inc.’s EPS estimate is -0.03.
How many shares outstanding does Airsculpt Technologies, Inc. have?
Airsculpt Technologies, Inc. has 72,095,210 shares outstanding.
What happened to Airsculpt Technologies, Inc.’s price movement after its last earnings report?
Airsculpt Technologies, Inc. reported an EPS of $0.01 in its last earnings report, missing expectations of $0.015. Following the earnings report the stock price went down -45.11%.
Which hedge fund is a major shareholder of Airsculpt Technologies, Inc.?
Currently, no hedge funds are holding shares in AIRS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Airsculpt Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (120.59% Upside)
$6.00 (120.59% Upside)
Blogger Sentiment
Bullish
AIRS Sentiment 100%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Increased
By 171.2K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-60.65%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Airsculpt Technologies, Inc.
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient’s own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company’s body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
AIRS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: the company demonstrated measurable stabilization (case growth, improved same-center sales, gross margin expansion, reduced debt and increased liquidity) and a clear strategic plan (new procedures, AlloClae partnership, marketing optimization). However, near-term headwinds persist — Q2 revenue modestly declined, adjusted EBITDA was down versus prior year, customer acquisition costs are elevated, and trends softened in June/July with Q3 expected to be down on a comparable basis. Management is investing in marketing and new services to drive longer-term growth but those investments and new offerings are early-stage and have not yet been fully realized in the financials.View all AIRS earnings summariesAIRS Stock 12 Month Forecast
Average Price Target
$6.00
▲(120.59% Upside)
Technical Analysis
AMN Healthcare Services
―
Community Health
―
―
Healthcare Services
―
National Healthcare
―
Ownership Overview
47.16% Insiders
1.25% Mutual Funds
47.09% Other Institutional Investors
2.45% Public Companies and
Individual Investors